Artwork

Content provided by British Society for Rheumatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by British Society for Rheumatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep 50. Modifiable risk factors and therapeutic targets in polymyalgia rheumatica

9:22
 
Share
 

Manage episode 488249839 series 3341497
Content provided by British Society for Rheumatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by British Society for Rheumatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica?

In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelian randomisation study. They cover the key findings, which include some novel loci and potential therapeutic targets for PMR, as well as the hallmarks of a good Mendelian randomisation study.

Further reading:

  1. Read Steven's full study in Rheumatology

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

  continue reading

50 episodes

Artwork
iconShare
 
Manage episode 488249839 series 3341497
Content provided by British Society for Rheumatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by British Society for Rheumatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica?

In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelian randomisation study. They cover the key findings, which include some novel loci and potential therapeutic targets for PMR, as well as the hallmarks of a good Mendelian randomisation study.

Further reading:

  1. Read Steven's full study in Rheumatology

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

  continue reading

50 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play